Bingjiang Han

Gasdermin D mediates doxorubicin-induced cardiomyocyte pyroptosis and cardiotoxicity via directly binding to doxorubicin and changes in mitochondrial damage

Bozhi Ye, Xiaowen Shi, Jianjiang Xu et al. · Translational research · 2022 · 64 citations

Cardiovascular Toxicity, Cardiomyopathy, Heart Failure +10

GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis

Jibo Han, Shanshan Dai, Lingfeng Zhong et al. · Hypertension · 2022 · 48 citations · Full text

Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses

Xiaowen Shi, Bin Zhang, Zhenliang Chu et al. · Cardiovascular Therapeutics · 2021 · 33 citations · Full text

Schisandra chinensis polysaccharides prevent cardiac hypertrophy by dissociating thioredoxin-interacting protein/thioredoxin-1 complex and inhibiting oxidative stress

Xiaowen Shi, Bingjiang Han, Bin Zhang et al. · Biomedicine & Pharmacotherapy · 2021 · 25 citations · Full text

Lipid Peroxidation, Thioredoxin-interacting Protein/thioredoxin-1 Complex, Redox Biology +16

Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes

Jibo Han, Zimin Fang, Bingjiang Han et al. · Nature Cardiovascular Research · 2023 · 24 citations

Deubiquitinase Josd2, Cardiomyopathy, Heart Failure +12